Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective, randomized study

Hepatology

Volumn 8, Issue 1, 1988, Pages 6-9

  Idéo, Gaetanǒ ^a   Bellati, Giorgio ^a   Fesce, Edoardo ^a   Grimoldi, Daniela ^a  

^a SANT ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NADOLOL; RANITIDINE;

CONTROLLED STUDY; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MORTALITY; ORAL DRUG ADMINISTRATION; PORTAL HYPERTENSION; PRIORITY JOURNAL;

CLINICAL TRIALS; COMPARATIVE STUDY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGE; NADOLOL; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RANITIDINE; TIME FACTORS;

EID: 0023928726     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080103     Document Type: Article

References (22)

1. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study
2. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report
3. The natural history of esophageal varices. A study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding
4. Prophylactic portacaval anastomosis. A tale of two studies
5. The course of patients after variceal hemorrhage
6. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices. A prospective controlled randomized trial
7. Prophylactic endoscopic sclero‐theraphy of oesophageal varices. A prospective controlled study
8. Beta‐adrenocep‐tor blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation
9. Redistribution of cardiac output to the kidneys during oral nadolol administration
10. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension
11. Use of a selective beta‐blocker, nadolol, in the treatment of portal hypertension in cir‐rhotics
12. Ranitidine increases lower oesophageal spincter pressure in man
13. Nature of bleeding of esophageal varices
14. Esophageal varices: comparative incidence of ulceration and spontaneous rupture as a cause or mortal hemorrhage
15. Esophagitis associated with haemorrhage from esophageal varices
16. A controlled study trial of cimeti‐dine in the recurrence of variceal hemorrhage: implications about the pathogenesis of hemorrhage
17. Tables of the number of patients required in clinical trials using the log‐rank test
18. Prediction of variceal hemorrhage by esophageal endoscopy
19. Transection of the oesophagus for bleeding oesophageal varices
20. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
21. Prophylactic portal non‐decompression surgery in patients with oesophageal varices